– CANADA, Vancouver – Wellbeing Digital Sciences Inc. (NEO: MEDI | OTC: KONEF |FRA: SQ2), an evidence-based healthcare company today announced the appointment of Najla Guthrie as CEO effective March 31, 2022, replacing Interim CEO Adam Deffett who will be continuing in his former capacity as VP of Capital Markets and Communications of the Company.
About
Ms. Guthrie is the current Chief Research Officer and President of KGK Science Inc., a London, Ontario-based business, to become a leading North American contract research organization that primarily provides high-quality clinical research trials with a focus on the nutraceutical, cannabis, and emerging psychedelic industries. Najla has published over 50 articles in peer-reviewed journals and has given numerous presentations at both the national and international levels. The Company’s management is grateful to have Ms. Guthrie join the leadership team and is excited to see how her contribution will create opportunities for the future.
“I am looking forward to leading the Company through its next stages of growth and development. Adam has exhibited great leadership during his tenure as Interim CEO and I am honored to take over the role at the end of the month. I would like to thank Adam in advance for a smooth transition at that time,” said Najla Guthrie, incoming CEO of Wellbeing.
She added: “I greatly appreciate the opportunity to lead Wellbeing as we continue to pursue our vision of becoming a leader in mental health and wellness across North America. We have a leadership team with great depth, decades of experience, and detailed knowledge of the industry. Naturally, I will continue to steward KGK Science forward as a leading clinical research organization.”
About Wellbeing Digital Sciences Inc.
Wellbeing Digital Sciences is an evidence-based healthcare company focused on innovative clinical solutions, artificial intelligence-powered digital therapeutics, and contract research. Its mission is supported by a network of North American clinics that provide ketamine-assisted therapies and other types of treatment to patients as well as through a contract research organization that offers clinical trials services to clients pursuing drug development. In essence, the company exists to make breakthrough treatments more accessible and to offer patients transformational experiences.
For more information: https://www.wellbeingdigital.co/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
